On January 11, 2019, Neuro and Cardiac Technologies, LLC (“Plaintiff”) filed a complaint against Neuronetics, Inc. (“Defendant”) for infringement of U.S. Patent No. 6,366,814 (“the ‘814 Patent”). The ‘814 Patent is assigned to the Plaintiff and is drawn to an external stimulator for adjunct treatment for neurological, neuropschiatric, and urological disorders. The Plaintiff is asserting that the Defendant is infringing the ‘814 Patent by making, selling, offering to sell, and/or importing its NeuroStar TMS Therapy® System. The case remains pending and is captioned 2:19-cv-00167 (E.D. Pa.).
By: April Breyer Menon